ampelopsin has been researched along with Inflammation in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (53.85) | 24.3611 |
2020's | 6 (46.15) | 2.80 |
Authors | Studies |
---|---|
He, X; Li, Y; Liu, D; Liu, T; Lv, W; Wang, Y | 1 |
Ahmad, H; Hou, X; Wang, T; Xu, Z; Zhang, H; Zhang, J | 1 |
Diao, Y; Guo, Y; Kou, X; Luo, L; Qi, S; Xin, Y; Yin, Z | 1 |
Cai, G; Hou, L; Hu, CY; Huang, B; Jiang, F; Jiang, Y; Liu, D; Wang, C; Zheng, W | 2 |
Fu, X; Jiang, S; Lai, EY; Li, S; Mao, J; Patzak, A; Peng, WX; Persson, PB; Qiu, X; Shu, Q; Tang, C; Wang, CH; Wang, W; Wang, X; Xu, Z; Yu, M; Zhang, G; Zhang, M; Zhao, L; Zhou, S; Zhu, R | 1 |
Chen, L; Deng, X; Deng, Y; He, G; He, J; Jiang, P; Kuang, D; Li, J; Li, R; Luo, J; Luo, S; Tan, S; Yan, M; Yang, D; Yang, Z; Yuan, Q; Zhou, Y; Zou, Y | 1 |
Cao, J; Chen, X; Lu, C; Qian, J; Wang, X; Zhang, W | 1 |
Fan, M; Guo, T; Han, D; Lin, J; Luo, J; Tao, L; Wu, B; Yi, F; Yuan, M | 1 |
Cheng, W; Deng, CJ; Jin, LP; Peng, N; Shao, L; Wei, GZ; Wu, J; Zhou, MQ | 1 |
Cheng, C; Feng, ZJ; Jiang, H; Liu, CM; Ma, JQ; Sun, JM; Yang, HX; Yang, W | 1 |
Guo, L; Yan, X; Zhang, H | 1 |
Jiang, SP; Jiang, ZH; Leung, EL; Li, T; Liu, J; Liu, L; Liu, Y; Su, XH; Wang, TY; Wong, VK; Wong, YF; Yan, FG; Yao, XJ; Yi, XQ; Zhou, H | 1 |
13 other study(ies) available for ampelopsin and Inflammation
Article | Year |
---|---|
Ampelopsin Improves Cognitive Impairment in Alzheimer's Disease and Effects of Inflammatory Cytokines and Oxidative Stress in the Hippocampus.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alzheimer Disease; Animals; Cognitive Dysfunction; Cytokines; Dinoprost; Disease Models, Animal; Flavonoids; Hippocampus; Inflammation; Male; Maze Learning; Memory, Short-Term; Neuroprotective Agents; Oxidative Stress; Rats | 2020 |
Evaluation of antioxidant activities of ampelopsin and its protective effect in lipopolysaccharide-induced oxidative stress piglets.
Topics: Amidines; Animals; Antioxidants; Apoptosis; Benzothiazoles; Biphenyl Compounds; Erythrocytes; Female; Flavonoids; Hemolysis; Hydrogen Peroxide; Inflammation; Injections, Intraperitoneal; Lipid Peroxidation; Lipopolysaccharides; Malondialdehyde; Oxidants; Oxidative Stress; Picrates; Protein Carbonylation; Sulfonic Acids; Superoxide Dismutase; Superoxides; Swine | 2014 |
Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cyclooxygenase 2; Cytokines; Dinoprostone; Flavonoids; Gene Expression; Inflammation; Lipopolysaccharides; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA, Messenger; Signal Transduction | 2012 |
Dihydromyricetin Ameliorates Inflammation-Induced Insulin Resistance via Phospholipase C-CaMKK-AMPK Signal Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Diabetes Mellitus, Type 2; Flavonols; Inflammation; Insulin Resistance; Male; Mice, Inbred C57BL; Signal Transduction | 2021 |
Dihydromyricetin resists inflammation-induced muscle atrophy via ryanodine receptor-CaMKK-AMPK signal pathway.
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Body Composition; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Line; Diet, High-Fat; Disease Models, Animal; Disease Susceptibility; Flavonols; Glucose; Inflammation; Male; Mice; Molecular Imaging; Muscle, Skeletal; Muscular Atrophy; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Tumor Necrosis Factor-alpha | 2021 |
Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis.
Topics: Acute Kidney Injury; Animals; Cisplatin; Ferroptosis; Inflammation; Kidney; Mice; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Reactive Oxygen Species | 2023 |
Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice.
Topics: Amidohydrolases; Animals; Apolipoproteins E; Arginine; Atherosclerosis; Enzyme Activation; Flavonols; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipid Metabolism; Lipids; Liver; Male; Mice, Inbred C57BL; MicroRNAs; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction | 2020 |
Dihydromyricetin attenuates D-galactose-induced brain aging of mice via inhibiting oxidative stress and neuroinflammation.
Topics: Aging; Animals; Antioxidants; Brain; Cellular Senescence; Flavonols; Galactose; Hippocampus; Inflammation; Malondialdehyde; Mice; Neuroprotective Agents; Oxidative Stress; Spatial Learning; Spatial Memory | 2021 |
Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice.
Topics: Animals; Apoptosis; Autophagy; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Flavonols; Inflammation; Male; Mice; Oxidative Stress | 2017 |
Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway.
Topics: Animals; Cardiotonic Agents; Cell Line; Cell Survival; Flavonols; Gene Expression Regulation; Inflammation; Inflammation Mediators; Lipopolysaccharides; Myocytes, Cardiac; NF-kappa B; Rats; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2017 |
Dihydromyricetin Inhibits Lead-Induced Cognitive Impairments and Inflammation by the Adenosine 5'-Monophosphate-Activated Protein Kinase Pathway in Mice.
Topics: AMP-Activated Protein Kinase Kinases; Ampelopsis; Animals; Apoptosis; Brain; Cognitive Dysfunction; Cytokines; Flavonols; Humans; Inflammation; Lead; Mice; NF-kappa B; Phosphorylation; Plant Extracts; Protein Kinases; Toll-Like Receptor 4 | 2018 |
Protective effect of dihydromyricetin revents fatty liver through nuclear factor‑κB/p53/B‑cell lymphoma 2‑associated X protein signaling pathways in a rat model.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; bcl-2-Associated X Protein; Disease Models, Animal; Fatty Liver; Flavonols; Gene Expression Regulation; Humans; Inflammation; Liver; NF-kappa B; Oxidative Stress; Rats; Signal Transduction; Superoxide Dismutase; Tumor Suppressor Protein p53 | 2019 |
Mutation of cysteine 46 in IKK-beta increases inflammatory responses.
Topics: Animals; Arthritis, Experimental; Cells, Cultured; Collagen Type II; Cysteine; Female; Flavonols; Flow Cytometry; Fluorescent Antibody Technique; Humans; Hypersensitivity, Delayed; I-kappa B Kinase; Immunoenzyme Techniques; Inflammation; Mice; Mice, Transgenic; Mutation; NF-kappa B; Phosphorylation; Rats; Rats, Wistar; Signal Transduction; T-Lymphocytes | 2015 |